Key facts
- It has raised $50K; the latest was Angel (individual) ($50K) in Nov 2025.
- Medication Data Science has filed 1 Form D with the SEC, most recently Nov 2025 ($50K sold to 1 investors).
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Medication Data Science
- ·The full record, as it builds
Funding rounds
No funding rounds for Medication Data Science are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Medication Data Science
Developer of AI-driven research approaches intended to improve provider well-being, health outcomes and patient experience. The company is currently operating in Stealth Mode.
- Sector
- Business Products and Services (B2B)
- HQ
- Ann Arbor, MI, United States
- Founded
- 2025
- Ownership
- Privately Held (backing)
Medication Data Science doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Medication Data Science shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Medication Data Science in its N-PORT filings yet. We sweep new filings monthly.